Dietary Minerals and Incident Cardiovascular Outcomes among Never-Smokers in a Danish Case-Cohort Study.
Victoria FruhTesleem K BabalolaClara SearsGregory A WelleniusThomas F WebsterKoren K MannJames M HarringtonAnne TjønnelandOle Raaschou-NielsenBirgit Claus HennJaymie R MelikerPublished in: International journal of environmental research and public health (2024)
Background: Diet is known to impact cardiovascular disease (CVD) risk, but evidence for the essential minerals of magnesium (Mg), calcium (Ca), and potassium (K) is inconsistent. Methods: We conducted a case-cohort study within a non-smoking subgroup of the Danish Diet, Cancer and Health cohort, a prospective study of 50-64-year-olds recruited between 1993-1997. We identified incident heart failure (HF), acute myocardial infarction (AMI) and stroke cases through 2015 with an 1135-member subcohort. We measured the dietary intake of minerals, also known as elements, and calculated a combined dietary intake (CDI) score based on joint Ca, Mg and K intakes (mg/d) from Food Frequency Questionnaires. We estimated adjusted hazard ratios (HRs) with Cox proportional hazard models. Results: Most HRs examining associations between CDI score and CVD were null. However, the third quartile of CDI was associated with a lower risk for heart failure (HR: 0.89; 95% CI: 0.67, 1.17), AMI (HR: 0.79; 95% CI: 0.60, 1.04), and stroke (HR: 0.63; 95% CI: 0.44, 0.88). Conclusions: We did not find consistent evidence to suggest that higher levels of essential minerals are associated with incident HF, AMI, and stroke, though results suggest a potential U-shaped relationship between select minerals and CVD outcomes.
Keyphrases
- acute myocardial infarction
- cardiovascular disease
- heart failure
- atrial fibrillation
- left ventricular
- percutaneous coronary intervention
- acute heart failure
- smoking cessation
- weight loss
- healthcare
- physical activity
- public health
- type diabetes
- human health
- mental health
- cerebral ischemia
- papillary thyroid
- squamous cell carcinoma
- cardiac resynchronization therapy
- coronary artery disease
- clinical trial
- randomized controlled trial
- protein kinase
- health information
- acute coronary syndrome
- cardiovascular risk factors
- squamous cell
- brain injury
- psychometric properties
- lymph node metastasis
- breast cancer risk